These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3082391)

  • 21. Continuous and intermittent infusion of coagulation factor concentrates in patients undergoing surgery: a single centre Australian experience.
    Campbell PJ; Rickard KA
    Aust N Z J Med; 1998 Aug; 28(4):440-5. PubMed ID: 9777111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specific therapy in hemophilia.
    Hutaff LW
    N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
    [No Abstract]   [Full Text] [Related]  

  • 23. Continuous infusion of coagulation factors.
    Batorova A; Martinowitz U
    Haemophilia; 2002 May; 8(3):170-7. PubMed ID: 12010406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment on demand--in vivo dose finding studies.
    Escobar MA
    Haemophilia; 2003 Jul; 9(4):360-7. PubMed ID: 12828669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program.
    Owaidah T; Momen AA; Alzahrani H; Almusa A; Alkasim F; Tarawah A; Nouno RA; Batniji FA; Alothman F; Alomari A; Abu-Herbish S; Abu-Riash M; Siddiqui K; Ahmed M; Mohamed SY; Saleh M
    Medicine (Baltimore); 2017 Jan; 96(2):e5456. PubMed ID: 28079788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemophilia in a Changing Treatment Landscape.
    Pelland-Marcotte MC; Carcao MD
    Hematol Oncol Clin North Am; 2019 Jun; 33(3):409-423. PubMed ID: 31030810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Haemophilia].
    Loomans JI; Lock J; Peters M; Leebeek FW; Cnossen MH; Fijnvandraat K
    Ned Tijdschr Geneeskd; 2014; 158():A7357. PubMed ID: 25351381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New viewpoints in the treatment of hemophilia].
    Göbel U
    Dtsch Med Wochenschr; 1973 Sep; 98(39):1814-6. PubMed ID: 4583442
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent advances in developing specific therapies for haemophilia.
    Ling G; Nathwani AC; Tuddenham EGD
    Br J Haematol; 2018 Apr; 181(2):161-172. PubMed ID: 29359795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subcutaneous infusion ports in the pediatric patient with hemophilia.
    Girvan DP; deVeber LL; Inwood MJ; Clegg EA
    J Pediatr Surg; 1994 Sep; 29(9):1220-3. PubMed ID: 7807350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defining severity of hemophilia: more than factor levels.
    Pavlova A; Oldenburg J
    Semin Thromb Hemost; 2013 Oct; 39(7):702-10. PubMed ID: 24026911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium.
    Mauser-Bunschoten EP; de Goede-Bolder A; Wielenga JJ; Levi M; Peerlinck K
    Neth J Med; 1998 Dec; 53(6):249-55. PubMed ID: 9883002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Capacity of activation of so-called deficient factors in hereditary blood coagulation disorders].
    Mingers AM
    Fortschr Med; 1976 Oct; 94(30):1723-5. PubMed ID: 1086815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemophilia.
    Tintinalli JE
    JACEP; 1977 Jul; 6(7):326-9. PubMed ID: 875253
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results of a cooperative programme of profilactic treatment for haemophilia A and B (author's transl)].
    Sangre (Barc); 1978; 23(5B):780-92. PubMed ID: 725718
    [No Abstract]   [Full Text] [Related]  

  • 37. [The occurrence of immunological tolerance to inhibitors of factors VIII and IX in hemophilia patients].
    Brakman GG
    Gematol Transfuziol; 1993 Feb; 38(2):18-20. PubMed ID: 8020714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor VIII and IX variants. Relationship between haemophilia B M and haemophilia B+.
    Meyer D; Larrieu MJ; Obert B
    Eur J Clin Invest; 1971 Sep; 1(6):425-31. PubMed ID: 5121733
    [No Abstract]   [Full Text] [Related]  

  • 39. Sensitivity of the reaction time of the resonance thrombogram for factor VIII:C and factor IX deficiencies in the blood of dogs with haemophilia A or B.
    Mischke R
    Haemophilia; 2000 Sep; 6(5):575-80. PubMed ID: 11012705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
    Kraiem I; Hadhri S; El Omri H; Sassi R; Chaabani W; Ennabli S; Skouri H
    Ann Biol Clin (Paris); 2012; 70(6):659-65. PubMed ID: 23207810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.